NCT04280302

Brief Summary

Vertigo / dizziness, imbalance and other symptoms related to vestibular pathology have a life prevalence of 7.4%. Peripheral and unilateral vestibulopathy are among the most common types, and in some patients the symptoms become chronic and disabling, which makes it difficult for them to lead a normal life and has a significant socio-economic impact. In recent years, the effect of vestibular rehabilitation with virtual reality has been studied and positive results have been obtained when compared with traditional rehabilitation, but despite rehabilitation there is patients who are still chronic, and the reasons for this prognostic variability are still unknown and require further treatment. Virtual reality-based stimulation can play a significant role as an adjunct to conventional vestibular rehabilitation, improving its effectiveness.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 14, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 21, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

February 21, 2020

Status Verified

February 1, 2020

Enrollment Period

1 year

First QC Date

February 14, 2020

Last Update Submit

February 20, 2020

Conditions

Keywords

vestibularunilateral vestibularvirtual realityrehabilitation

Outcome Measures

Primary Outcomes (1)

  • Change pre-post treatment in the Dizziness handicap inventory (DHI) (0-100)

    Change within subjects from baseline to the end of week 4

    4 weeks

Secondary Outcomes (8)

  • Change pre-post treatment in Posturography (Wii+software RombergLab)

    4 weeks

  • Change pre-post treatment in Test up and go (TUG)

    4 weeks

  • Change pre-post treatment in Berg Scale (0-56)

    4 weeks

  • Change pre-post treatment in Tinneti Test (1-28)

    4 weeks

  • Change pre-post treatment in Simulator Sickness Questionnaire (SSQ) (0-14)

    4 weeks

  • +3 more secondary outcomes

Study Arms (2)

Virtual reality based therapy

EXPERIMENTAL
Behavioral: Virtual Reality-based Rehabilitation

Conventional Therapy

ACTIVE COMPARATOR
Behavioral: Conventional Therapy

Interventions

VR-based eye stabilization exercises and balance exercises

Virtual reality based therapy

Conventional rehabilitation therapy based on eye stabilization exercises and balance exercises

Conventional Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral vestibular deficit
  • Vestibular neuritis
  • Sudden hearing loss with vestibular involvement
  • Labyrinthitis
  • Ménière's disease
  • Vestibular Shwannoma
  • Benign paroxysmal positional vertigo
  • Vestibular symptoms (vertigo, dizziness, imbalance, gait instability, kinosis and / or oscillopsy) chronic (more than 6 weeks of evolution)
  • Over 18 years old

You may not qualify if:

  • Neurological, traumatological, rheumatological, ophthalmological or systemic pathology that may interfere with the balance
  • Inability to understand participation in the study
  • Non-acceptance to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitari de Tarragona Joan XXIII

Tarragona, 43005, Spain

RECRUITING

Study Officials

  • Sandra Sáez Felipe

    ssaezfelipe@gmail.com

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sandra Sáez Felipe

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

February 14, 2020

First Posted

February 21, 2020

Study Start

January 1, 2020

Primary Completion

January 1, 2021

Study Completion

March 1, 2021

Last Updated

February 21, 2020

Record last verified: 2020-02

Locations